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This review examines the developments in optical biosensor technology, which uses the phenomenon of surface
plasmon resonance, for the detection of paralytic shellfish poisoning (PSP) toxins. Optical biosensor technology
measures the competitive biomolecular interaction of a specific biological recognition element or binder with a
target toxin immobilised onto a sensor chip surface against toxin in a sample. Different binders such as receptors
and antibodies previously employed in functional and immunological assays have been assessed. Highlighted are
the difficulties in detecting this range of low molecular weight toxins, with analogues differing at four chemical
substitution sites, using a single binder. The complications that arise with the toxicity factors of each toxin
relative to the parent compound, saxitoxin, for the measurement of total toxicity relative to the mouse bioassay
are also considered. For antibodies, the cross-reactivity profile does not always correlate to toxic potency, but
rather to the toxin structure to which it was produced. Restrictions and availability of the toxins makes
alternative chemical strategies for the synthesis of protein conjugate derivatives for antibody production a
difficult task. However, when two antibodies with different cross-reactivity profiles are employed, with a toxin
chip surface generic to both antibodies, it was demonstrated that the cross-reactivity profile of each could be
combined into a single-assay format. Difficulties with receptors for optical biosensor analysis of low molecular
weight compounds are discussed, as are the potential of alternative non-antibody-based binders for future assay
development in this area.
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Introduction
Paralytic shellfish poisoning (PSP) toxins are naturally
occurring potent neurotoxins synthesised by micro-
scopic dinoflagellates from the genii Alexandrium,
Gymnodinium and Pyrodinium in marine and freshwa-
ter environments (Reis Costa et al. 2009). Increased
temperatures, sunlight and nutrient-rich waters are
considered to cause the rapid reproduction of dinofla-
gellate species and thereby lead to potential ‘harmful
algal blooms’. Climate change, increased ocean eutro-
phication and commercial shipping are believed to
contribute to the increasing frequency and occurrence
of these blooms worldwide (Botana et al. 2009). Filter-
feeding organisms, such as molluscan shellfish, con-
suming dinoflagellates may thereby accumulate
the PSP toxins and potentially transfer them
through the trophic chain (Deeds et al. 2008). The
toxins do not appear to harm shellfish directly, but are
potentially lethal to humans or other consumers
such as marine mammals and birds (Huang et al.
1996).
No visible difference in appearance is observed
between harmless and toxic shellfish. As the PSP
toxins are heat stable they are not destroyed by
cooking, but due to their solubility in water leaching
into the cooking water occurs (Michalski 2007;
Etheridge 2010), and canning procedures are
reported to reduce toxin levels for this reason
(Vieites et al. 1999). Following consumption the
toxins bind with a high affinity to site 1 of the
voltage-dependent sodium channel -subunit of
muscle and nerve cells, blocking the influx of
sodium and preventing the generation and propaga-
tion of action potentials in these excitable cells
(Cestele and Catterall 2000). Early symptoms follow-
ing ingestion include tingling of the lips and tongue,
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followed by the loss of control of arms and legs.
Difficulty in breathing ensues from paralysis of the
muscles of the chest and abdomen, which results in
death at high toxin doses. Fatal levels of less than
1mg of the reference toxin saxitoxin (STX) have
been reported (van Egmond et al. 2004). There is
currently no antidote for intoxication with artificial
respiration as the palliative care until the toxin is
excreted from the body.
PSP has major implications to public health and
thereby seriously threatening economic consequences
in coastal communities and aquaculture industries
worldwide. Therefore, globally shellfish destined for
human consumption are routinely monitored for PSP
toxins by regulatory bodies. The internationally
accepted and European Union reference method of
analysis for PSP toxins in shellfish is the Association
of Analytical Communities (AOAC)-accredited bio-
logical method (AOAC 2005a) or more commonly
referred to mouse bioassay. Using this method
shellfish are deemed fit for consumption based on
a regulatory limit, which in Europe is 800mg of PSP
toxins per kg of shellfish meat, a level which has
been established for the prevention of acute poison-
ing (European Commission 2004). In some other
countries this limit is lower (Campas et al. 2007).
However, both ethical issues relating to the use of
animals and technical concerns unfolding in relation
to interference and sensitivity of the assay, particu-
larly if European Food Safety Authority
(EFSA) recommendations for lowering the regula-
tory limit are to be considered, is advancing the
search for alternative methods of analysis (EFSA
2009).
As a family group, both the chemical and
biological properties of the PSP toxins categorise
the task of developing an alternative method as
extremely challenging from any analytical perspec-
tive. Chemically, there are more than 20 common
PSP toxins (Figure 1) that vary in structure at four
main sites (R1–R4) of the parent compound STX
(Llewellyn 2006a). The toxins are classified into
groups based on the chemical substitutions at R4
as carbamate, decarbamoyl, sulfocarbamoyl and
deoxydecarbamoyl. The carbamoyl and decarbamoyl
toxins are the most toxic, whereas the sulfocarba-
moyl toxins have a much lower potency. In contrast
to the leaching of PSP toxins from shellfish to water
it is interesting to note, however, that in the
processing of canned seafood contaminated with
PSP toxins, the sulfocarbamoyl toxins may be
hydrolysed to the more toxic groups, which will
increase the overall PSP toxicity (Christian and
Luckas 2008). In the last number of years due to
advances in mass spectrometry new structural ana-
logues are also being identified (Dell’Aversano et al.
2008). Biologically, each analogue displays a different
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Figure 1. Structure, relative molecular mass (RMM) and toxicity factor of paralytic shellfish poisoning (PSP) toxins.
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which results in different toxicities relative to saxi-
toxin (Genenah and Shimizu 1981). Therefore, the
CONTAM Panel of EFSA recommended that the
regulatory limit to be expressed as mg STX-equiva-
lents per kg of shellfish meat (EFSA 2009), which
was accepted by the European Community. This
method of expression of total toxicity or total level
of contamination is therefore a simple concept for
the biological methods whereby toxin levels correlate
to toxicity and therefore the regulatory limit directly.
However, this causes severe complications for both
biochemical and analytical methodologies whereby
conversion factors are required especially when
certain toxin standards are limited or unavailable
for all detectable PSP toxins in a contaminated
sample.
Toxicity-equivalence factors (TEFs) (Figure 1),
originally determined by Oshima (1995) and provided
as supplementary material for available toxin stan-
dards by the National Reference Centre in Canada
(NRC), are used for the conversion of the individual
toxin amounts to STXdiHCl equivalents. However, the
EFSA working group on STX has recommended new
TEFs that are due to be implemented later in 2010 in
Europe with the major difference being that the TEF
for dcSTX will double in value.
The use of TEFs has supported the development
of analytical methods for PSP toxin analysis that can
then be correlated to the mouse bioassay and the
regulatory limits. Analytical methods such as high-
performance liquid chromatography (HPLC) with
fluorescence detection, using post-column (Oshima
1995; Asp et al. 2004) and pre-column oxidation
methods (Lawrence and Niedzwiadek 2001;
Lawrence et al. 2004, 2005), have been developed
for the determination of PSP toxins. The method of
Lawrence has now been AOAC accredited and
accepted following rigorous validation studies by
the European Union as a first action method for the
toxins for which it is validated (AOAC 2005b).
However, HPLC methods are slow, labour intensive
and analytical standards are difficult to obtain.
Oxidation of PSP toxins is required for HPLC with
fluorescence detection because they lack a chromo-
phore. For the AOAC HPLC method two oxidation
steps (peroxide and periodate) are required resulting
in two analytical runs. Lack of standard material,
lengthy purification procedures and insufficient
detectability has inhibited the progress in the devel-
opment of other techniques such as mass spectro-
metry for routine monitoring. Though advances in
mass spectrometry are being made through the use
of a zwitterionic hydrophilic interaction chromatog-
raphy column (Diener et al. 2007), nevertheless mass
spectrometry methods are more suitable for confir-
matory analysis rather than screening methods due
to their high expenditure and the requirement of
dedicated skilled scientists for processing the data for
quantitative analysis. Hence, alternative screening
methods are still sought that are effective and
suitable for routine on-site monitoring by unskilled
personnel. Different functional assays, biochemical
and biosensor-based technologies employing various
binding molecules have shown some potential as
alternative screening methods, but surface plasmon
resonance (SPR) optical biosensor technology has
shown considerable promise in this field in a
relatively short period of time. This review describes
SPR optical biosensor technology and the progress
and problems to date in developing an SPR assay for
PSP toxin detection for full acceptance as a regula-
tory tool. Highlighted is a feasibility study of how
combining binders has the potential to overcome
certain issues and discussed are the possibilities of
new novel binders with this technology.
Surface plasmon resonance (SPR) optical biosensor
technology
SPR is a powerful physical technique that measures
changes in refractive index and, therefore, in the
resonance angle by which polarised light is reflected
from a surface which is in turn related to a change
in mass on that surface (Subrahmanyam et al. 2002).
It is a phenomenon used to measure biomolecular
interactions in real time in a label-free environment.
These biomolecular interactions can be used to
identify the binding of two or more interactants to
each other to determine the affinity of the interac-
tions, to measure the actual association and dissoci-
ation rates of the interaction, and for the purpose of
PSP toxin detection can be exploited to quantify the
concentration of one of the interactants (Karlsson
2004).
Optical biosensors based on SPR technology are
now an established tool in biomedical research for
exploring molecular interactions but are increasingly
being investigated as monitoring tools by academic
and industrial scientists interested in food safety for the
detection of additives and contaminants.
As Biacore biosensors had been proven to be a
successful platform for detecting low-level chemical
contaminants and toxins in food products, the
Biacore Q platform was selected for assay develop-
ment for the monitoring of PSP toxins (Campbell
et al. 2007; Fonfria et al. 2007). This biosensor-based
assay measured the real-time interaction of a specific
biological recognition element or binder with a target
toxin immobilised onto the sensor chip surface. A
typical sensorgram, a measure of the binding
response against time, is illustrated in Figure 2
(Abery 2001). The running buffer flowing over the
Food Additives and Contaminants 713surface established the baseline value and as the
sample solution passed over the sensor surface, the
profile of the molecular interaction appeared.
During injection the observed binding rate was the
difference between the molecules binding to the
surface and molecules leaving the surface.
Consequently, binding appears fastest at the begin-
ning of the injection as the binder in the sample
readily interacts with the high concentration of
available toxin-binding partners on the sensor sur-
face. As the injection continues, the observed rate of
binding decreased as fewer toxin molecules are
available on the surface. After the injection was
complete, the binder dissociated and was washed
away by the continuous flow of buffer. The sensor
surface was regenerated back to the baseline value
for the analysis of the next sample (Campbell et al.
2007).
The SPR optical biosensor method for PSP toxins
was designed as an inhibition assay. A set amount of
PSP binder was mixed with the sample and injected
over the surface of a sensor chip to which toxin was
immobilised. When no PSP toxins were present in the
sample, the binder was then free to bind to the
immobilised toxin producing a response (Figure
3a) (Campbell et al. 2007). When PSP toxins were
present in the sample, these then bound to the binder,
which inhibited the binder from binding to the
immobilised toxin on the chip surface and a lower
response was produced (Figure 3b) (Campbell et al.
2007). For most biomolecules the change in response is
proportional to the mass of the material that has
bound to the surface. Therefore, for binders to elicit a
change in response from the baseline, they must be
greater than 1000 daltons and hence this is why the low
molecular weight toxins are immobilised to the surface.
Using this assay format, the level of binding to the
surface was inversely proportional to the concentration
of PSP toxins present in the sample. Figure 4 shows a
typical response against a concentration calibration
curve.
Further developments in optical SPR biosensor
technology, particularly the progression of multichan-
nel and multiplex instruments such as the Biorad
Proteon XPR36 (http://www.bio-rad.com) or Biacore
prototype developed as part of the European Union
6th Framework Project BioCop (http://www.biocop.
org), provide additional options for dealing with
toxicity factors of toxins and cross-reactivity issues of
binders. Within the European Union 7th Framework
programme the project CONffIDENCE is evaluating
the BioCop multiplex optical SPR for developing a
single assay for multiple toxin groups legislated by the
European Union and emerging toxins to European
Union waters (http://www.conffidence.eu). This mul-
tiplex prototype device is a four-channel instrument
with four detection spots within each channel allow-
ing for the simultaneous analysis of up to 16 differ-
ent analytes in a sample. This increases the scope of
binder interactions that could be employed to detect
the different PSP analogues. An ideal scenario
would be to have a highly specific binder for each of
the main PSP toxin groups. Each binder assay for each
group could be isolated in separate channels for
simultaneous detection in a sample, and then not
only would the analyst be able to determine if PSP
toxin was present, but also to which group it belonged
and a correlation made of the toxic potency level for
that sample.
Binders for SPR analysis of PSP toxins
A number of different types of binder have been
exploited in the development of various methodologies
for the detection of PSP toxins. These include receptors
such as the sodium channel receptor (SCR) and
saxiphilin receptor, polyclonal and monoclonal anti-
bodies raised against various toxin analogues and
chemical binders (Llewellyn and Doyle 2001; Usleber
et al. 2001; Gawley et al. 2007; van Dolah et al. 2009).
The general advantages and disadvantages of binders
that have been previously investigated in the develop-
ment of assays for SPR analysis for PSP toxins are
highlighted in Table 1.
Receptors
Receptors can be either cell membrane bound or
cytoplasmic proteins that may be exploited for their
ligand-binding capabilities for screening methodologies
based on their functional response. SCRs from crude
rat brain membrane preparations have been used in
radioligand binding assays (Wiegele and Barchi 1978)
and in recent years they have been configured into a
microtitre plate format (Powell and Doucette 1999;
Figure 2. SPR optical biosensor sensorgram of the molecular
interaction between the binder and immobilised surface.
Source: Abery (2001). Courtesy: Biacore International AB,
GE Healthcare.
714 K. Campbell et al.Ruberu et al. 2003). This microtitre plate format has
recently undergone successful single-laboratory valida-
tion (van Dolah et al. 2009). The fact that all STX
analogues bind to SCRs with affinities that vary
according to their toxic potency (Doucette et al.
1997) indicates that receptor-based competitive bind-
ing assays provide a measure of a sample’s toxicity,
irrespective of which PSP toxin(s) is present. The
saxiphilin receptor, occurring naturally in various
amphibians and terrestrial invertebrates, has also
been integrated into a competitive binding assay
using a microtitre plate format (Llewellyn and Doyle
2001). Llewellyn (2006b) studied the behaviour of
mixtures of PSP toxins in these two unrelated compet-
itive binding assays and found that the most potent
toxins affect the toxicity of the mixture to the greatest
extent with the less active toxins present required to be
several orders of magnitude greater for the mixture to
reflect their potency.
Receptor ligand binding assays using SPR technol-
ogy had previously been investigated (Gestwicki et al.
2001; De Jong et al. 2005). As receptor binders for PSP
toxins reflect toxicity in a similar manner to the mouse
bioassay, it was envisaged that they could be an ideal
candidate for the development of an SPR assay to
replace the mouse bioassay. Campbell et al. (2007)
examined crude extracts of SCR from rat brains using
SPR analysis, but technical difficulties were encoun-
tered with the SCR in that this preparation appeared to
be stable for only a short time at 4C, which in effect
was detrimental to reliability and reproducibility.
Another issue with developing SPR assays for small
molecular weight toxins is that when the toxin is
immobilised onto the surface, the toxin may then be
orientated in such a manner that it no longer locks into
the binding site of the receptor pocket, making the
toxin unrecognisable with minimal to no binding
occurring. As SPR is dependent on changes in mass,
for the receptor to be immobilised on the toxin surface
the toxin binding in isolation is not of a large enough
mass to achieve a change in response and the signal
would need to be amplified. Amplification could be
performed in a manner similar to a sandwich assay by
using a secondary antibody. For small molecular
weight compounds this is difficult to achieve due to a
Figure 3. SPR optical biosensor inhibition assay format.
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Figure 4. Typical response versus PSP toxin concentration
calibration curve using a polyclonal antibody binder.
Food Additives and Contaminants 715limited numbers of available epitopes that are not
already encapsulated in the receptor pocket. A differ-
ent approach that could be investigated is using a
ligand of a high molecular weight that would complete
and dissociate appropriately with the toxin for the
receptor site when the receptor is immobilised on
the surface (Karlsson 1994). This ligand would provide
the molecular mass necessary for the SPR response,
but sourcing a suitable competitor to PSP toxins
maybe difficult. The limited availability of the sax-
iphillin receptor to only a few research groups has
inhibited the characterisation of this binder in the role
of PSP toxin detection by SPR. Research is on-going
into the synthesis of cloned receptors that would prove
beneficial in both functional assays and as more stable
alternative binders to antibodies for sensor
technologies.
Antibodies
Antibodies unlike receptors are biochemical binders
and bind selectively to chemical moieties on the
structure of the toxin to which they are produced.
These binders do not show a similar correlation
between the toxicity of a toxin and binding affinity in
the same manner as receptors for PSP toxins. The
difficulty in trying to detect such small molecular
weight compounds using antibodies is that there are
limited functional groups to conjugate a protein for
antibody production based on site specificity and,
therefore, few chemical reactions can be utilised for
immunogen synthesis. Restricted and limited
availability of toxins makes the synthesis of alternative
derivatives impractical unless sufficient yield can be
achieved for immunogen production. The formation of
the toxin protein conjugate must also reduce the
toxicity of the toxin or when immunised the animal
may be affected with PSP symptoms. The first
antibodies produced against PSP toxins were reported
by Johnston et al. (1964). For most PSP toxin
antibodies produced since then either a modification
of the Mannich reaction or reductive alkylation
chemistry (Bu ¨ rk et al. 1995) has been employed for
the synthesis of the protein conjugate. As highlighted
by Usleber et al. (2001) during these reactions there are
three potential reactive sites for the carbamate toxins.
These include the amino, guanidine and imine groups,
but it is difficult to characterise which is the predom-
inant orientation of the toxin to the protein conjugate
or the ratio of protein conjugation to all three sites.
Immunochemical methods are frequently used for
qualitative, semi-quantitative and quantitative mea-
surements of many chemical substances with high
biological impact. These methods are well established
in clinical chemistry and endocrinology and have
become in recent years more sophisticated in their
use for food and environmental analysis and toxicol-
ogy screening due to their ability to function effectively
in complex biological matrices without major purifi-
cation. From the production of the first antibodies for
PSP toxins, it was decades later when immunoassays
were actually utilised to monitor PSP toxins in
shellfish. Immunoassay methods for PSP toxins have
been reviewed in the past (Usleber et al. 2001) and
several antibody-based approaches for detecting these
Figure 5. Trends in carbamate toxin response at a fixed concentration of 10ngml
1 with increasing percentage of NEO antibody
in STX/NEO antibody binder mix. Source: Campbell et al., unpublished data.
716 K. Campbell et al.toxins have been described since that time. These
include radioimmunoassay (Carlson et al. 1984),
immunoaffinity columns (Dietrich et al. 1996), lateral
flow devices (Jellett et al. 1998; Laycock et al. 2010)
and numerous competitive enzyme immunoassays
(EIAs). Indirect EIAs have been developed for STX
(Chu and Fan 1985; Cembella et al. 1990; Micheli et al.
2002), neosaxitoxin (NEO) (Chu et al. 1992; Bu ¨ rk
et al. 1995) and gonyautoxin (GTX) 2/3 (Kawatsu
et al. 2002) and direct EIAs for STX and NEO
(Usleber et al. 1991; Schneider et al. 1995; Chu et al.
1996; Huang et al. 1996; Dubois et al. 2010) and GTX
2/3 (Kawatsu et al. 2002). These assays all utilise
antibodies produced using the previously mentioned
protein conjugation chemistries with the primary
modification being the PSP toxin to which the protein
is conjugated. Although several EIAs and lateral
flow test kits are commercially available (Laycock
et al. 2010; http://www.abraxiskits.com; http://
www.biosense.com; http://www.r-biopharm.com),
one shortcoming is that they are highly specific to
certain toxins. This specificity, corresponding mainly
to chemical structure but not proportionately to
toxicity, limits an accurate measure of the total toxicity
in a sample as required by regulatory authorities. For
such diverse potency within this relatively large toxin
group, whose small molecular weight structures are
highly similar, it is extremely difficult to match the
cross-reactivity profile of an antibody to the potency of
each toxin for similar comparability as a receptor assay
to the mouse bioassay. Usleber et al. (2001) state that
from an immunological point of view the PSP toxin
family must be subdivided into STX (non-hydroxy-
lated) and NEO (hydroxylated) groups. Previous
ELISA studies have demonstrated that when the
antibodies are specific to either group they are less
specific to the other. Therefore, to incorporate the full
spectra of PSP toxins to an equivalent extent,
antibodies produced to both the non-hydroxylated
(STX) or hydroxylated toxins (NEO) will have to be
utilised. Other drawbacks to these commercial kits are
the high costs, primarily due to the availability and
Table 1. General advantages and disadvantages of binders previously assessed for SPR analysis of PSP toxins.
Binder Advantages Disadvantages
Receptors Have a binding affinity that generally correlates
with the biological response or toxicity of the
toxins
Can be isolated rapidly compared with antibody
production
Good sensitivity
Wider scope of binding to all compounds that act
on the same receptor
Have to be isolated form biological tissues and in
some cases the species of origin is difficult to
obtain
May display poor stability
May be temperature sensitive for analytical
purposes
Monoclonal antibodies Constant renewable source of binder once pro-
duced with minimal batch to batch variation
During production less immunizing agent is
required compared with polyclonal produc-
tion and it is possible to select for specific
epitope specificities and generate antibodies
against a wider range of antigens
React with a single epitope on an antigen with
high specificity
Binding affinity for the immunizing antigen is
generally better than a receptor
Less background signal than polyclonal
antibodies
For production, time, effort and commitment is
high and use animals
On average the binding affinity of a monoclonal
antibody is lower than a polyclonal antibody
As monoclonal antibodies are highly specific to a
single epitope they may lose affinity to other
antigens within a group with minor molecular
modifications
The binding affinity of an antibody does not
correlate with biological response for a toxin
group
Antibodies sometimes display unexpected cross-
reactivity with unrelated antigens in biological
matrices
Polyclonal antibodies For production relatively quick and inexpensive
to produce compared with monoclonal anti-
bodies
Polyclonals will recognize multiple epitopes on
any one antigen and are therefore more
tolerant of minor changes in the antigen than
monoclonal antibodies providing better cross-
reactivity to structural antigens within a group
The recognition of multiple epitopes generally
provides more robust detection
Binding affinity for the immunizing antigen is
generally better than a monoclonal antibody
or receptor
Animals are required and are prone to batch to
batch variability
They produce large amounts of
non-specific antibodies which can sometimes
give background signal in some applications
Multiple epitopes make it important to check for
any cross-reactivity in biological matrixes
The binding affinity of an antibody does not
correlate with biological response for a toxin
group
Food Additives and Contaminants 717quantity of toxin required for producing either coating
antigen or enzyme labels, and the potentially subjective
interpretation of results.
Current progress of SPR analysis of PSP toxins
using antibody binders
To date although antibodies may have specificity issues
relating to the analysis of such a large toxin group they
are the most successful binder in terms of sensitivity for
the detection of PSP toxins. For this reason antibodies
were chosen as the model binder to demonstrate the
feasibility of SPR optical biosensor technology for PSP
toxin analysis. The applicability of SPR analysis to this
task was demonstrated using both a monoclonal
antibody (GT-13A) raised to gonyautoxin 2/3 and a
polyclonal antibody (R895) raised to STX (Campbell
et al. 2007). When an STX surface was employed,
which can be regenerated over 1000 times for reuse
conserving toxin supplies and reducing cost, these two
antibodies displayed vast differences in their cross-
reactivity profiles. The GT-13A binder showed a high
degree of segregation between non-hydroxylated and
hydroxylated toxins indicating that when samples are
analysed and compared with the mouse bioassay using
this binder the toxin content of a sample would be
underestimated if the toxin composition is predomi-
nately the hydroxylated toxins, NEO or GTX1/4
(Campbell et al. 2007). However, PSP toxins such as
C1/C2 and GTX5 displayed high specificity, although
their toxic potency is relatively low to STX. Therefore,
samples containing levels of these toxins will over-
estimate compared with the mouse bioassay. For
regulatory purposes, underestimation could have
severe health implications to the consumer whereby
contaminated material is declared safe for consump-
tion, whereas overestimation could cause detrimental
economic losses to the industry through the unneces-
sary closure of harvesting beds. This GT-13A binder
was further assessed by SPR to determine its tolerance
capabilities to various shellfish matrices and PSP toxin
extraction solvents (Fonfria et al. 2007). Fonfria et al.
applied different extraction procedures, previously
employed for PSP toxin analysis, to different shellfish
species and they highlighted that by either using an
ethanolic extraction procedure reported by Garthwaite
et al. (2001) or the AOAC HPLC acetic acid extraction
(AOAC 2005b), the determination of PSP toxins in
shellfish could be performed by SPR. The Garthwaite
method was recommended for further evaluation based
on analysis time, but only 50% recovery of STX was
achieved using this extraction procedure. However,
samples containing C1/C2 toxins overestimated com-
pared with HPLC and mouse bioassay results due to
the low toxic potency but high specificity of this toxin.
As a proof of concept this monoclonal antibody was
also employed to demonstrate that SPR biosensor-
based biochemical analysis could be combined with
state-of-the-art mass spectrometry chemical analysis
for joint screening and confirmatory determination of
PSP toxins (Marchesini et al. 2009).
The R895 binder showed a much more diverse
but narrower pattern in cross-reactivity profile with
improved sensitivities to all toxins compared with
GT-13A, but the hydroxylated toxins dcNEO and
GTX1/4 will require further improvement. Rawn et al.
(2009) performed an evaluation of both binders by
SPR using the Garthwaite extraction procedure for
analysing 88 natural samples and compared the results
with the AOAC HPLC method (AOAC 2005b). This
study demonstrated that when using this extraction
procedure, different shellfish matrix effects were con-
siderable compared with a buffer curve, and if a buffer
curve were used for analysis, this would cause an
overestimation in results of 50%. Therefore, natural
samples were evaluated using an extracted mussel
calibration curve for better correlation in recovery and
matrix effects. In general, the polyclonal antibody
correlated better with HPLC than the monoclonal
antibody due to the differences in cross-reactivity
profiles. However, it was recommended that improved
antibody response to the hydroxylated toxins would
be necessary if SPR were to be a replacement for the
mouse bioassay for regulatory testing. As a screening
tool, it was suggested that this SPR method using
either antibody could eliminate greater than 80% of
samples from the mouse bioassay at the current
regulatory limit. In relation to the three Rs of replace,
reduce and refine at this stage, the SPR assay may not
be a replacement tool but a reduction tool for the
number of animal assays performed for regulatory
purposes.
Further work was then performed on the extraction
procedure in order to calibrate the SPR assay using a
buffer curve to eliminate the requirement of sourcing
uncontaminated material and using relatively excessive
quantities of toxin in the preparation of a calibration
curve (Campbell et al. 2009). This was achieved in a
comparative study using a second polyclonal binder
raised to STX (BC67) for SPR analysis compared with
EIA, HPLC and mouse bioassay (Campbell et al.
2009). This study demonstrated that the key for
immunological assay development was the binder and
highlighted that the advantages of using SPR over all
the other methods were simplicity, ease of use and
speed of analysis. This new extraction procedure using
pH 5 sodium acetate buffer followed by centrifugation
followed by dilution and analysis was then applied to
the STX antibody and a single laboratory validation of
this SPR method performed highly satisfactorily
(Campbell et al. 2010). An inter-laboratory study
between seven international laboratories is currently
underway. Threshold values for the assay have been
718 K. Campbell et al.discussed for regulatory purposes, but this level could
vary depending on geographical location and the risk-
management strategies that have to be considered
whether by industrial or by regulatory monitoring
laboratories. To date there has been no reports of PSP
toxins occurring in isolation, but if GTX1/4 were to do
so, this method could then become invalid even as a
screening tool due to the lack of sensitivity of this
binder to this toxin. Therefore, alternative binders are
still being sought with improved sensitivity towards the
hydroxylated toxins and different heterologous assay
formats are being investigated that could improve the
overall toxicity determination of PSP toxins in a
sample.
A combination of two binders, one raised to STX
(Campbell et al. 2007), the other to NEO (Bu ¨ rk et al.
1995), were assessed on a NEO chip surface to deter-
mine the feasibility of combining the cross-reactivity
profiles of each in order to be able to detect the full
range of PSP toxins in isolation at the regulatory level
(Campbell et al., unpublished data). The sensitivity and
specificity of each binder relative to STX and its
analogues were assessed. The cross-reactivity profile
of the STX and NEO antibodies on the NEO surface
was favoured to the non-hydroxylated and hydroxyl-
ated toxins at the R1 position respectively (Table 2).
The percentage cross-reactivity of STX antibody in
relation to STXdiHCl was variable in relation to toxin
structure with the NEO surface. Toxins with modifi-
cations in the R4 position (Figure 1) displayed the
highest percentage cross-reactivity followed by those
with modifications to the R2 and R3 positions and
then those toxins hydroxylated in the R1 position.
Combinations of modifications showed an additive
decreaseinpercentagecross-reactivitywiththeoutcome
for GTX1/4, which is modified at the R1, R2 and R3
positions, displaying the lowest percentage cross-
reactivity at1.0%. For the NEO antibody binder
the chemical reaction used to prepare the chip surfaces
wasdifferentfromthereactionusedtopreparethetoxin
protein conjugate used as the immunogen. A change in
orientation of the toxin conjugated to the surface could
explain the relatively low antibody titres required to
produce a response on this NEO chip surface in relation
to the titre of this antibody reported in the ELISA study
(Bu ¨ rk et al. 1995). This antibody was significantly
more sensitive to the R1 hydroxylated toxins compared
with the corresponding non-hydroxylated toxins as in
agreement with the ELISA study.
Initially for the carbamate toxins different ratios of
STX antibody to NEO antibody titres were assessed
with the most suitable for the mix study being 1/500
and 1/50, respectively. Different percentage ratios of
STX to NEO antibody at these dilutions were assessed
using the neosaxitoxin chip surface and each of the
carbamate toxins at a concentration of 10ngml
1
(Figure 5). The full cross-reactivity profile was deter-
mined using an optimum 20% STX and 80% NEO
antibody (Table 3) as this ratio showed the lowest
differential in cross-reactivity for the carbamate toxins.
On comparison with the cross-reactivity profile of STX
and NEO antibody on their own with this surface,
Table 2. Sensitivity and specificity data for both STX and NEO antibody on a NEO chip surface (Campbell et al., unpublished
data).
Chip surface Neosaxitoxin chip surface
Antibody STX NEO
Antibody dilution in HBS-EP 1/250 1/50
Antibody ratio to standard 1:1 1:1
Flow rate (mlmin
1)2 5 2 5
Contact time (min) 2 2
PSP toxin analogue
IC50
(ngml
1)
Percentage
cross-reactivity
Dynamic range,
IC20 to IC80
(ngml
1)
IC50
(ngml
1)
Percentage
cross-reactivity
Dynamic
range,
IC20 to IC80
(ngml
1)
Saxitoxin dihydrochloride 4.8 100 2.7–8.1 41.8 100 6.6–203
Neosaxitoxin 13.4 35.8 3.7–84.8 2.4 1742 1.1–5.5
Gonyautoxin 1/4 474
b 1.0
b 77–2780
b 4.1 1032 1.6–14.9
Gonyautoxin 2/3 7.0 68.7 2.1–22.0 19.6 213 4.1–91.6
Decarbamoyl saxitoxin 2.9 165.1 1.3–6.3 41000 54.2 n.d.
a
Decarbamoyl neosaxitoxin 100 4.8 14.4–200 192.1 21.8 41.9–512
Decarbamoyl gonyautoxin 2/3 18.7 25.8 4.4–62.3 41000 54.2 n.d.
C1/C2 14.8 32.6 3.3–53.6 41000 54.2 n.d.
Gonyautoxin 5 4.1 117 2.7–7.7 41000 54.2 n.d.
C3/C4 206
b 2.3
b 27–590
b 100 41.3 n.d.
Notes:
an.d., Not determined due to lack of the standard.
bValues calculated based on extrapolation of the four-parameter fit applied to the standard curve due to availability of the
standard.
Food Additives and Contaminants 719the cross-reactivity profile has been amalgamated to
produce a potential single-assay format for all PSP
toxins. With the exceptions of GTX5 and dcSTX,
which will overestimate based on this cross-reactivity
profile, this antibody mix correlates much better than
either binder individually with the mouse bioassay
toxicity factors (Figure 1) for each of the toxins. This is
illustrated in Table 3 as the cross-reactivity profile in
STXdiHCl equivalents.
Consequently, by using optical SPR biosensor
analysis, there is the potential to resolve cross-
reactivity issues that arise using a single binder.
Combining the two polyclonal antibodies STX and
NEO with a common denominator of the NEO surface
enabled the design of a single-assay format for both
hydroxylated and non-hydroxylated toxins. In addi-
tion, as the cross-reactivity is more in line with the
toxicity profile for the mouse bioassay, this is an
advantage in having one screening test for all PSP
toxins compared with two ELISA tests. This approach
of mixing antibodies raised in the same species could be
used for other families of chemical contaminants or
toxins where there is significant variability in the cross-
reactivity profile as long as there is a common
denominator in the family for chip surface
immobilisation.
Potential binders for future optical SPR analysis
of PSP toxins
A wide range of non-antibody-based binders have been
reviewed previously as alternative molecules for the
detection of pathogens (Ngundi et al. 2006). The most
promising non-antibody binders worth investigating
in their role for PSP toxin analysis by SPR are
chemosensors (Bell and Hext 2004), molecular
imprinted polymers (MIPs) (Hall et al. 2005) and
aptamers (Tombelli et al. 2005). The advantages and
disadvantages of these particular binders are high-
lighted in Table 4.
Chemosensors
Chemists have used a variety of approaches to design
artificial receptors or chemosensors capable of selec-
tively binding analytes. Chemosensors are molecules
specifically designed for the qualitative and quantita-
tive monitoring of analytes and are being researched
in the areas of biological and analytical chemistry,
medicine and environmental sciences (Bell and Hext
2004; Minkin et al. 2008). These molecules bind to the
target analyte through non-covalent interactions and
produce a change in light absorption or fluorescence.
Molecular structures that have displayed some poten-
tial as chemosensors are polyalcohols, crown ethers,
calixarenes, helicenes, sterically geared tripods, metal
complexes, pinwheels, porphyrins and fused ring het-
erocycles. Most chemosensors described do not display
sufficient sensitivity or selectivity to their targets for
practical applications, and they usually require syn-
thetic modification for immobilisation onto a sensor
surface. However, chemosensors such as crown
ether sensors like calix[4]arene have been investi-
gated as alternative binders for STX detection
Table 3. Sensitivity and specificity of the STX/NEO antibody mix for each PSP toxin (Campbell et al., unpublished data).
STX 1/500
Antibody dilution in HBS-EP NEO 1/50
Antibody mix 20% STX/80% NEO
Antibody ratio to standard 1:1
Flow rate (mlmin
1)1 2
Injection volume (ml) 60
Contact time (min) 5
Toxin concentration
(ngml
1)
Toxin concentration
as STXdiHCl
equivalents (ngml
1)
PSP toxin analogue
IC50
(ngml
1)
Percentage
cross-reactivity
Dynamic range,
IC20 to IC80
(ngml
1)
IC50
(ngml
1)
Percentage
cross-reactivity
Dynamic range,
IC20 to IC80
(ngml
1)
Saxitoxin dihydrochloride 2.8 100 0.2–68.8 2.8 100 0.20–68.8
Neosaxitoxin 2.8 100 0.8–9.9 3.1 90.3 0.87–10.8
Gonyautoxin 1/4 4.4 63.6 0.8–25.3 4.0 70 0.72–22.8
Gonyautoxin 2/3 4.9 57.1 0.9–28.0 2.9 96.6 0.54–16.8
Decarbamoyl saxitoxin 0.4 700 0.1–1.2 0.3 933 0.07–0.9
Decarbamoyl neosaxitoxin 9.1 30.7 1.7–48.7 6.4 43.8 1.19–34.2
Decarbamoyl gonyautoxin 2/3 17.1 16.4 3.1–94.7 6.8 41.1 1.23–37.7
C1/C2 14.5 19.3 2.0–102.7 1.1 255 0.15–7.7
Gonyautoxin 5 0.4 700 0.1–1.5 0.03 9333 0.01–0.1
C3/C4 91.8 3.0 24.0–198 4.0 70 1.03–8.5
720 K. Campbell et al.(Chen et al. 2007). These binders are showing consid-
erable promise in detecting STX using fluorescence,
but as yet the sensitivity is five orders of magnitude
lower than that achievable using the mouse bioassay
(Gawley et al. 2002, 2007). For naturally contaminated
shellfish samples there was no correlation between the
intensity of absorption and toxicity of the sample.
However, SPR spectroscopic detection using these
binders increased the sensitivity up to 1000-fold (Chen
et al. 2007). Shellfish matrices have not as yet been
evaluated.
Molecular imprinted polymers (MIPs)
MIPs have received controversial exposure over the
past 10 years from researchers and industries in their
potential role in the environmental and food analysis
of chemical contaminants and toxins (Lotierzo et al.
2004; Henry et al. 2005; Baggiani et al. 2008). They are
artificially created ligand binding sites that can selec-
tively recognise a target molecule. The synthesis
involves the polymerisation of functional and cross-
linking monomers around the target of interest or a
structural mimic template through non-covalent inter-
actions or reversible covalent bonds or both with the
functional groups of the template. These three-dimen-
sional polymer-based systems can be optimised to yield
recognition sites highly specific and selective to the
target of interest in the same manner as either a
polyclonal or a monoclonal antibody. However, the
mechanism of interaction or recognition of a particular
analyte to the polymer is still not completely compre-
hended. Unlike antibodies, these are fairly rigid mac-
roscopic structures are insoluble in any solvent. MIPs
therefore are more commonly marketed and used for
Table 4. Advantages and disadvantages of potential binders for SPR analysis of PSP toxins.
Binder Advantages Disadvantages
Chemosensors Non-animal-based binders
Can be incorporated into self-assembly
monolayers for sensing on a surface
Lower binding affinity than antibodies
No correlation between the binding
intensity and biological response or
toxicity
Molecular imprinted polymers (MIPS) Non-animal-based binder
Target analyte defines its own recogni-
tion site
Stable at extreme temperature and pH
Show specificity in natural systems
Adaptable and flexible in their use
Low cost and ease of manufacture
May be used in non-aqueous media or
aggressive environments
May be sensitive to small alterations in
target analyte structure and
properties
Show non-specific binding
Diversity of binding sites
Template bleeding requires suitable
template analogue for imprinting
and affects quantitative applications
Generally lower binding affinities than
antibodies
Aptamers Nucleic acid aptamers are non-animal-
based binders produced by chemical
synthesis resulting in limited batch to
batch variation
Selectively bind to low molecular
weight compounds
Binding affinities of aptamers are in the
mM to nM range and kinetic
parameters can be altered on
demand
Toxins that do not illicit a good
immune response can be used to
generate high-affinity aptamers
Aptamers are stable for long-term
storage and can be transported at
ambient temperature
Selection conditions can be manipu-
lated to obtain aptamers with prop-
erties desirable for in vitro assays,
e.g. non-physiological buffers,
solvents, etc.
Reporter molecules can be attached to
aptamers at precise locations so as
not to affect binding
Aptamers are costly to generate and
long aptamer sequences are difficult
to achieve
DNA aptamers have a smaller range of
three-dimensional structures obtain-
able compared with RNA aptamers
but they can bind their target to the
entire sequence
DNA and RNA aptamers are suscep-
tible to enzymatic degradation by
nucleases, thus requiring highly pure
environments. This can be overcome
Peptide aptamers are constrained to the
scaffold protein so they are less
flexible, which may affect their
effectiveness. Only the variable range
is used for binding
Peptide aptamers require biological
systems for selection purposes
Food Additives and Contaminants 721selectively separating molecules for clean-up and pre-
concentration of analytes from complex samples, but
they have also been demonstrated in detection assays
(Ramstrom et al. 2001; Chianella et al. 2003). The
applicability of MIPs as a surface template in the SPR
analysis of domoic acid has also been demonstrated
(Lotierzo et al. 2004). Mahony et al. (2005) stated that
combinatorial chemistry and computational molecular
modelling are the most promising concepts for the
development of MIPs for enhanced recognition prop-
erties. Using this technology with advances in poly-
meric materials, in the future there is the potential to
develop and design binders with the highest selectivity
to the PSP toxin family as a whole. However, the
elimination of problems associated with template
leaching for quantitative analysis would have to occur.
Aptamers
Aptamers, first described by Tuerk and Gold (1990),
are creating a new wave of enthusiasm as alternative
binders to antibodies due to progress in aptamer
screening methods (Wang and Jia 2009) and their
potential in the field of aptasensors (Wilner and Zayats
2007). Aptamers can be divided into those created
from polymers of nucleic acids (RNA and DNA) or
amino acids (peptides). Nucleic acid aptamers are
small synthetic oligonucleotides of up to 100 base pairs
that can bind specifically to a variety of targets, such as
whole cells, proteins, drugs, toxins and low molecular
weight compounds, with affinities in the nanomolar
and sub-nanomolar ranges. They can bind with a high
affinity and specificity to a target molecule through
complementary shape interactions as a result of their
three-dimensional shape. Nucleic acid aptamers are
produced by an in vitro process called systematic
evolution of ligands by exponential enrichment
(SELEX) (Stoltenburg et al. 2007). These aptamers
can provide high molecular discrimination in being
able to distinguish differences in a methyl group
between two compounds (Jenison et al. 1994).
Aptamers offer several distinct advantages compared
with antibodies or receptors. They are isolated in vitro,
and the targets are of a broad spectrum. Following
aptamer selection, DNA aptamers with a long shelf life
can be prepared with high batch consistency and low
cost by automated DNA synthesis, and RNA aptamers
can be prepared by simple in vitro transcription.
Aptamers are also simple to modify and introduce
various reactive groups, affinity tags or reporting
moieties essential for biosensor applications. Nucleic
acid aptamers have a limited number of structures
compared with peptide aptamers, but offer better
structural stability. Protein scaffolds are an adaptation
of peptide aptamers that may overcome stability issues.
Peptide aptamers still require biological systems for
selection purposes. Aptamers have been demonstrated
in therapeutic applications, in the field of separation
chemistry, in environmental and food analysis of
chemical contaminants and toxins, and in a number
of aptasensor applications (Tombelli et al. 2007;
Wilner and Zayats 2007; Stead et al. 2010). These
binders are now developing rapidly and may be the one
binder group that in future replaces antibodies for
diagnostic and detection applications. To date, they
offer the best opportunity of finding a single binder for
the detection of the whole PSP toxin family or
individual binders for each of the varying toxic
groups within this family.
Conclusion
Optical SPR biosensor analysis for PSP toxin detection
has been demonstrated over the past five years to be
a highly effective rapid screening method that has the
potential to reduce the vast number of mouse bioassays
performed worldwide. This review has highlighted the
key problems associated with antibody cross-reactivity
in over- and underestimating total toxicity and how, by
using a dual antibody binder system with a generic
surface, there is the potential to adjust the cross-
reactivity profile to help overcome this problem.
Alternative non-antibody-based binders, however,
may offer a complete non-animal-based methodology
for the detection of PSP toxins by SPR. In addition,
advances in SPR technology, with the development
of multiplexing multichannel instruments, could help
resolve some of the difficulties in binder specificity not
relating to toxicity. Multiplex multichannel SPR bio-
sensors with highly designed binders such as nucleic
acid aptamers (Mok and Li 2008) may be the way
forward not only for monitoring phycotoxins, but also
for a wide variety of food additives and contaminants.
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